In vivo inhibition of dopamine beta-hydroxylase by 1-phenyl-3-(2-thiazolyl)-2-thiourea (U-14,624).
D000311:Adrenal Glands / Q000502:physiology; D000315:Adrenalectomy; D000818:Animals; D001921:Brain / Q000187:drug effects / Q000201:enzymology / Q000378:metabolism*; D001923:Brain Chemistry; D002247:Carbon Isotopes; D002395:Catecholamines / Q000378:metabolism*; D004221:Disulfiram / Q000494:pharmacology; D004298:Dopamine / Q000032:analysis; D018492:Dopamine Antagonists; D006867:Hydrolases / Q000037:antagonists & inhibitors*; D008297:Male; D008680:Metaraminol / Q000494:pharmacology; D051379:Mice; D008996:Monoamine Oxidase Inhibitors / Q000494:pharmacology; D009206:Myocardium / Q000378:metabolism; D009638:Norepinephrine / Q000032:analysis / Q000096:biosynthesis / Q000378:metabolism; D051381:Rats; D013045:Species Specificity; D013844:Thiazoles / Q000494:pharmacology*; D013890:Thiourea / Q000494:pharmacology*; D013997:Time Factors; D014316:Tritium; D014443:Tyrosine / Q000378:metabolism
D002247:Carbon Isotopes; D002395:Catecholamines; D018492:Dopamine Antagonists; D008996:Monoamine Oxidase Inhibitors; D013844:Thiazoles; D014316:Tritium; D014443:Tyrosine; D008680:Metaraminol; D006867:Hydrolases; D013890:Thiourea; D004221:Disulfiram; D004298:Dopamine; D009638:Norepinephrine